Skip to main navigation
Skip to Content
logo
  • About
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Financial Reports
    • Annual Reports
    • Quarterly & Other Reports
    • SEC Filings
  • Stock Info
    • Stock Quote and Chart
    • Historic Stock Lookup
    • Investment Calculator
  • Analyst Coverage
  • Corporate Governance
    • Documents and Charters
    • Our Team
    • Committee Composition
  • Investor Resources
    • Email Alerts
    • Contact Us

News Releases

News Releases

Keyword Search

Apr-12-2016
Oncternal Awarded Exclusive Worldwide License to ROR1 Antibody and Related Programs from UCSD

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Current page 14
Print
RSS Feeds
Email Alerts
Contact IR
Search
  • © 2023 Oncternal Therapeutics, Inc. All rights reserved.